Clinical Trials Logo

Clinical Trial Summary

A Phase 2 trial of avelumab plus gemcitabine in advanced leiomyosarcoma as a second line treatment


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03536780
Study type Interventional
Source Gachon University Gil Medical Center
Contact Young Saing Kim, MD, PhD
Phone +82-032-460-3231
Email zoomboom@gilhospital.com
Status Recruiting
Phase Phase 2
Start date October 1, 2018
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05099666 - Lurbinectedin + Doxorubicin In Leiomyosarcoma Phase 1/Phase 2